Updated 2/23/26
Universal Health Realty Income Trust, or UHT for short, has been quietly doing what a lot of REIT investors wish more companies would—providing a steady, long-term stream of income. Since launching back in 1986, UHT has focused on owning and leasing out healthcare-related real estate. Think hospitals, surgical centers, and medical office buildings. These aren’t speculative properties; they’re essential infrastructure for healthcare providers, often operated under long leases.
The trust’s primary tenant is Universal Health Services (UHS), which manages many of the facilities in its portfolio. That tie-in has helped give the company a level of reliability when it comes to cash flow, and that’s a big deal for dividend-focused investors.
Now, let’s dig into what’s been happening recently and what it all means for those who rely on UHT for income.
Recent Events
As of February 23, 2026, shares of UHT are trading at $43.14—near the upper end of the 52-week range of $35.26 to $44.14. The stock has recovered meaningfully from its lows and is now sitting within striking distance of its one-year high, a sign that the market has grown more comfortable with healthcare REITs after a period of rate-driven turbulence. With a beta of 0.93, UHT remains one of the lower-volatility names in the REIT space, which continues to attract income-focused investors looking for stability.
The most recent quarterly dividend payment came in at $0.745 per share, paid in December 2025, representing another incremental increase in UHT’s long streak of annual raises. There have been no major asset sales or large-scale acquisitions announced recently, which is consistent with management’s historically deliberate approach to portfolio management. The broader interest rate environment remains a watchpoint, as UHT carries a substantial debt load and rising borrowing costs continue to pressure REIT margins across the sector. Still, operating cash flow of $48.6 million over the trailing twelve months provides a reasonable cushion for the current dividend commitment.
Key Dividend Metrics
📈 Forward Dividend Yield: 6.84%
💵 Forward Annual Dividend: $2.98 per share
📊 5-Year Average Dividend Yield: 5.69%
🎯 Payout Ratio: 228.68% (net income basis)
📅 Last Dividend Paid: $0.745 per share (December 22, 2025)
📈 Trailing 12-Month Dividend Growth: Up from $2.90 to $2.98 per share
📆 Consecutive Years of Dividend Increases: Over 39 years
Dividend Overview
UHT’s appeal to income investors remains intact heading into 2026. The current dividend yield of 6.84% sits well above the trust’s own five-year average of 5.69%, making today’s price look relatively attractive from an income perspective even as the stock approaches its 52-week high of $44.14. The annual dividend now stands at $2.98 per share, ticking up from the $2.90 range of the prior year as management continued its pattern of small, deliberate quarterly increases.
Looking at the recent dividend history tells the story clearly. Payments have moved steadily upward—from $0.715 in early 2023 to $0.745 by December 2025—with each increase modest but consistent. That kind of discipline is exactly what long-term income investors are looking for. The latest quarterly payment of $0.745 per share, paid December 22, 2025, keeps the streak intact at over 39 consecutive years of annual increases.
The reported payout ratio of 228.68% based on net income will understandably catch attention, but it requires context. REITs depreciate physical real estate assets heavily under GAAP accounting, which compresses net income without reflecting actual cash generation. Operating cash flow of $48.6 million on roughly 13.9 million shares outstanding works out to approximately $3.50 per share in cash flow—ahead of the $2.98 annual dividend. The coverage is tight but defensible, and it’s consistent with how UHT has operated for decades.
Dividend Growth and Safety
UHT has never been a high-growth dividend story, and that’s by design. The increases are incremental—a penny or two per quarter—but they’ve been uninterrupted for nearly four decades. That consistency is the core of the investment thesis for income-focused holders, and management has shown no signs of abandoning that approach. Over the trailing twelve months, the annualized dividend moved from $2.90 to $2.98, a gain of roughly 2.8%. It’s not going to outpace inflation significantly, but in a sector prone to cuts during economic stress, sustained growth is its own form of outperformance.
Free cash flow of $40.3 million over the past year further supports the dividend’s durability. Capital expenditures have been measured, leaving a healthy share of operating cash flow available for distributions and debt servicing. The trust’s profit margin of 17.79% and return on equity of 10.55% are respectable for a healthcare REIT of this size and structure.
Debt remains a relevant consideration. UHT’s leverage is material, and with interest rates staying elevated relative to pre-2022 levels, those financing costs are a real drag on free cash flow. However, the trust’s operating model—long-term leases with healthcare tenants in a non-cyclical sector—provides the revenue predictability needed to manage that load. Insider ownership also remains meaningful, keeping management’s incentives closely aligned with those of shareholders receiving quarterly dividend checks. The healthcare real estate sector simply doesn’t experience the demand swings that retail or office REITs do, which underpins the income stream’s long-term resilience.
Cash Flow Statement
Universal Health Realty Income Trust generated $48.6 million in operating cash flow over the trailing twelve months, a step up from the $46.9 million reported in the prior period and a reflection of continued steady rent collection from its healthcare-focused portfolio. Free cash flow came in at approximately $40.3 million after accounting for capital expenditures, leaving a meaningful buffer relative to the trust’s annual dividend obligation of roughly $41.4 million at the current rate. The gap is narrow, but it’s consistent with how UHT has historically managed its distributions.
Investing outflows remained measured, in line with the trust’s conservative approach to acquisitions and capital improvements. Financing activities continued to reflect dividend payments as the largest cash use, with partial debt transactions rounding out that category. Net income of $17.9 million for the period, while depressed relative to cash flow by non-cash depreciation charges, still reflects a profitable operation generating real earnings from its leased properties. Interest expense remains an area to watch given the elevated rate environment, but operating cash flow coverage of the dividend—while tight—remains intact. UHT’s cash position at period end is modest, which is typical for a trust that distributes the majority of its income, but short-term liquidity metrics remain manageable.
Analyst Ratings
Formal analyst coverage of Universal Health Realty Income Trust remains sparse. UHT is a small-cap healthcare REIT with a market capitalization of approximately $598.5 million, and niche names of this size often attract limited sell-side attention. The absence of recent published ratings is not unusual for UHT and doesn’t in itself signal deteriorating fundamentals—it more reflects the trust’s position as a focused, under-the-radar income vehicle rather than a widely traded institutional name.
From a fundamental standpoint, the case for the stock at $43.14 is nuanced. The price sits near the top of its 52-week range, which means the margin of safety from a valuation perspective is somewhat compressed. The P/E ratio of 33.44 is elevated by traditional measures, though again, net income underrepresents true cash generation for REITs. A price-to-book of 3.77 on a book value of $11.43 per share suggests investors are paying a significant premium for the trust’s income reliability and track record. Short interest of 297,780 shares is low relative to the float, indicating minimal bearish positioning—a signal that the stock isn’t drawing significant skepticism from sophisticated market participants at current levels.
For dividend-focused investors, the combination of a 6.84% yield above the five-year average, stable operating cash flow, and over 39 years of consecutive increases makes the income story compelling even without bullish analyst consensus to point to. The risks around leverage and tenant concentration are real and should be weighed, but they’re also well-understood factors that have been part of the UHT equation for years without disrupting the dividend stream.
Earning Report Summary
Steady Operational Results
Universal Health Realty Income Trust’s most recently available financial data reflects the kind of quiet, consistent performance that characterizes this trust. Revenue over the trailing twelve months came in at $100.9 million, crossing the $100 million threshold and representing growth from the $99 million reported for full-year 2024. Net income reached $17.9 million, or $1.29 per diluted share. While that figure is below the $19.2 million and $1.39 per share posted in 2024, it remains squarely in the range of what UHT has historically delivered, and the variance is largely attributable to fluctuations in non-cash items and interest expense rather than any deterioration in the operating business.
Cash Flow Remains the Real Story
For REIT investors, net income is a starting point rather than the finish line. Operating cash flow of $48.6 million is the more meaningful measure here, and it reflects genuine improvement in the trust’s cash-generating ability. Free cash flow of $40.3 million after capital expenditures represents a healthy portion of the dividend commitment, confirming that UHT is funding its distributions with real cash rather than financial engineering. Return on assets of 4.02% and return on equity of 10.55% are solid for a healthcare REIT of this scale and leverage profile.
Portfolio and Property Activity
The trust’s revenue growth past the $100 million mark reflects continued leasing activity and the gradual maturation of properties added in recent years. UHT’s portfolio remains anchored by long-term leases with healthcare operators, providing revenue predictability that supports both the dividend and the debt service schedule. No major new acquisitions have been announced recently, keeping the balance sheet from stretching further while allowing existing assets to continue contributing to the cash flow base.
Balance Sheet Considerations
The trust’s capital structure continues to carry meaningful leverage, which is standard in the REIT sector but warrants attention given the sustained higher-rate environment. Interest expense has been a headwind on net income, and UHT’s management has historically used interest rate hedging tools—such as fixed-rate swap agreements—to manage that exposure and protect cash flow predictability. The profit margin of 17.79% reflects the reality of those interest costs while still demonstrating that the core business generates real earnings from its healthcare real estate portfolio.
Management Team
Universal Health Realty Income Trust is led by a stable, experienced team that has been at the company’s core for decades. At the top is Alan B. Miller, who has served as Chairman of the Board, President, and Chief Executive Officer since UHT was established in 1986. Miller also founded Universal Health Services (UHS), one of the country’s leading hospital operators, which provides additional depth and perspective to UHT’s healthcare focus.
Alongside him is Charles F. Boyle, the Senior Vice President and Chief Financial Officer. Boyle has been with the trust since the early ’90s and took on the CFO role in 2003. His financial leadership has helped maintain consistency in reporting and capital allocation through various market cycles.
Another long-serving member of the leadership team is Cheryl K. Ramagano, Senior Vice President of Operations, Treasurer, and Secretary. Ramagano has been integral to the trust’s daily operations since 1992, managing treasury functions and operational oversight with a steady hand. Collectively, this leadership team offers deep knowledge of the healthcare REIT space and has guided UHT through multiple market environments with a consistent, long-term focus.
Valuation and Stock Performance
As of February 23, 2026, UHT is trading at $43.14, near the high end of its 52-week range of $35.26 to $44.14. The stock’s recovery from the low end of that range represents meaningful appreciation, and income investors who added shares during the pullback toward $35 have been rewarded with both price gains and a higher entry yield. At today’s price, the 6.84% yield still sits well above the trust’s five-year average of 5.69%, which suggests the market hasn’t fully priced away the income opportunity even as the stock has moved higher.
The current P/E ratio of 33.44 is elevated by most standards, but as with any REIT, this metric is distorted by depreciation charges that reduce reported earnings without reflecting cash outflows. Price-to-book of 3.77 on a book value of $11.43 per share indicates investors are paying a substantial premium for the trust’s income reliability and four-decade dividend track record—a premium that has historically been justified by the consistency of results. Return on assets of 4.02% is modest but reasonable within a sector where large property portfolios carry significant book value relative to operating income.
UHT’s market capitalization of approximately $598.5 million keeps it in small-cap territory, which limits institutional ownership and analyst coverage but also means the stock doesn’t face the same institutional selling pressure that larger REITs do during sector rotations. For dividend growth investors, the combination of a near-7% yield, conservative management, and 39-plus years of consecutive increases remains a compelling package even at current valuations.
Risks and Considerations
There are a few notable risks to keep in mind. One is UHT’s relatively high level of leverage. The debt-to-equity ratio remains well above 2.0, meaning the trust relies heavily on borrowing to fund its operations and property base. This isn’t unusual for a REIT, but in today’s interest rate environment, higher financing costs continue to weigh on net income and leave less room for flexibility if revenue were to soften unexpectedly.
Another point of consideration is UHT’s close business relationship with Universal Health Services, which operates many of the trust’s leased properties. While this relationship has historically been a source of cash flow stability, it also creates meaningful tenant concentration risk. If UHS were ever to face financial or operational difficulties, the ripple effect on UHT’s rental income and property occupancy could be significant.
Broader industry risks include healthcare policy changes, regulatory shifts, and local market dynamics. Healthcare real estate tends to be more stable than office or retail, but it’s not immune to disruption—particularly if reimbursement models evolve or facility utilization patterns shift. With the stock trading near its 52-week high of $44.14, there is also limited price-based margin of safety at current levels, making the dividend yield and cash flow durability the primary justification for holding at this price point.
Final Thoughts
Universal Health Realty Income Trust continues to do what it has always done: generate predictable income from a focused portfolio of healthcare real estate, managed by a leadership team that has been in place for decades and has never deviated from its long-term orientation. The annual dividend has now grown to $2.98 per share, extending one of the longest consecutive increase streaks in the REIT sector to over 39 years, and operating cash flow of $48.6 million provides the foundation to sustain that commitment.
At $43.14, the stock isn’t offering the deep-value entry points that emerged when it dipped toward $35 earlier in the past year. But a 6.84% yield that sits meaningfully above the five-year average still makes a reasonable case for income-focused investors, particularly those who prioritize stability and predictability over growth. The risks around leverage and tenant concentration are real, but they’re also well-understood and have been managed responsibly through multiple market cycles.
In the end, UHT represents a focused, deliberate approach to healthcare real estate. It moves at its own pace, doesn’t chase headlines, and continues to reward investors who value steady cash flow over fast gains. For the right kind of investor—one who measures success in decades rather than quarters—that profile remains as relevant as ever.